{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:13:04Z","timestamp":1761585184006,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["31363"],"award-info":[{"award-number":["31363"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.intimp.2018.12.033","type":"journal-article","created":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T23:12:40Z","timestamp":1545088360000},"page":"319-325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Th1, Th2, Th17 cell subsets in two different immunosuppressive protocols in renal allograft recipients (Sirolimus vs mycophenolate mofetil): A cohort study"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3673-364X","authenticated-orcid":false,"given":"Atefeh","family":"Eteghadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Pak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedram","family":"Ahmadpoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeideh","family":"Jamali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mozhdeh","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mir Saeed","family":"Yekaninejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parviz","family":"Kokhaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsen","family":"Nafar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Akbar","family":"Amirzargar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.intimp.2018.12.033_bb0005","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1053\/j.ajkd.2015.01.026","article-title":"Transplant immunology and immunosuppression: core curriculum 2015","volume":"65","author":"Hricik","year":"2015","journal-title":"Am. J. Kidney Dis."},{"issue":"1","key":"10.1016\/j.intimp.2018.12.033_bb0010","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.trim.2014.05.002","article-title":"Focus on mTOR inhibitors and tacrolimus in renal transplantation: pharmacokinetics, exposure\u2013response relationships, and clinical outcomes","volume":"31","author":"Shihab","year":"2014","journal-title":"Transpl. Immunol."},{"issue":"24","key":"10.1016\/j.intimp.2018.12.033_bb0015","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1056\/NEJMoa020009","article-title":"The natural history of chronic allograft nephropathy","volume":"349","author":"Nankivell","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.intimp.2018.12.033_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042011","article-title":"Dysregulation of Th17 cells during the early post-transplant period in patients under calcineurin inhibitor based immunosuppression","volume":"7","author":"Chung","year":"2012","journal-title":"PLoS One"},{"year":"1996","series-title":"The Actions of Cyclosporin A and FK506 on T-lymphocyte Activation","author":"Mattila","key":"10.1016\/j.intimp.2018.12.033_bb0025"},{"issue":"1","key":"10.1016\/j.intimp.2018.12.033_bb0030","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.immuni.2013.01.004","article-title":"Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy","volume":"38","author":"Liao","year":"2013","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.intimp.2018.12.033_bb0035","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1161\/HYPERTENSIONAHA.110.162917","article-title":"FK506 binding protein 12 deficiency in endothelial and hematopoietic cells decreases regulatory T cells and causes hypertension","volume":"57","author":"Chiasson","year":"2011","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.intimp.2018.12.033_bb0040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.it.2014.10.006","article-title":"Intersection of mTOR and STAT signaling in immunity","volume":"36","author":"Saleiro","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.intimp.2018.12.033_bb0045","first-page":"336","article-title":"Differential regulation of regulatory T cells and Th17 cells by mTOR inhibitor in kidney transplant recipients","volume":"13","author":"Kim","year":"2013","journal-title":"Am. J. Transplant."},{"issue":"8","key":"10.1016\/j.intimp.2018.12.033_bb0050","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ki.2010.492","article-title":"Mycophenolate mofetil-based immunosuppression with sirolimus in renal transplantation: a randomized, controlled Spare-the-Nephron trial","volume":"79","author":"Weir","year":"2011","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.intimp.2018.12.033_bb0055","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/ki.2014.350","article-title":"Cellular and molecular immune profiles in renal transplant recipients after conversion from tacrolimus to sirolimus","volume":"87","author":"Gallon","year":"2015","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.intimp.2018.12.033_bb0060","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/TP.0b013e3181927a41","article-title":"Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial","volume":"87","author":"Schena","year":"2009","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.intimp.2018.12.033_bb0065","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jss.2013.11.1085","article-title":"Impact of single immunosuppressive drug withdrawal on lymphocyte immunoreactivity","volume":"188","author":"Verma","year":"2014","journal-title":"J. Surg. Res."},{"issue":"9","key":"10.1016\/j.intimp.2018.12.033_bb0070","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1097\/TP.0000000000000717","article-title":"Differential effects of calcineurin and mammalian target of rapamycin inhibitors on alloreactive Th1, Th17, and regulatory T cells","volume":"99","author":"Gallon","year":"2015","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.intimp.2018.12.033_bb0075","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.trre.2013.06.001","article-title":"Review of combination therapy with mTOR inhibitors and tacrolimus minimization after transplantation","volume":"27","author":"Peddi","year":"2013","journal-title":"Transplant. Rev."},{"key":"10.1016\/j.intimp.2018.12.033_bb0080","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/731426","article-title":"Comparable renal function at 6\u202fmonths with tacrolimus combined with fixed-dose sirolimus or MMF: results of a randomized multicenter trial in renal transplantation","volume":"2010","author":"Van Gurp","year":"2010","journal-title":"J. Transplant."},{"issue":"3","key":"10.1016\/j.intimp.2018.12.033_bb0085","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/01.tp.0000167757.63922.42","article-title":"A prospective, randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 1\u202fyear","volume":"80","author":"Mendez","year":"2005","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.intimp.2018.12.033_bb0090","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1590\/S0101-28002009000400004","article-title":"Sirolimus efficacy, tolerability, and safety for treatment after kidney transplantation","volume":"31","author":"Oliveira","year":"2009","journal-title":"J. Bras. Nefrol."},{"issue":"1","key":"10.1016\/j.intimp.2018.12.033_bb0095","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.trim.2009.02.002","article-title":"Quantitative analysis of regulatory T cells in kidney graft recipients: a relationship with calcineurin inhibitor level","volume":"21","author":"Calvo-Turrubiartes","year":"2009","journal-title":"Transpl. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2018.12.033_bb0100","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.healun.2010.04.012","article-title":"Increased Th17 rather than Th1 alloimmune response is associated with cardiac allograft vasculopathy after hypothermic preservation in the rat","volume":"29","author":"Syrj\u00e4l\u00e4","year":"2010","journal-title":"J. Heart Lung Transplant."},{"issue":"2","key":"10.1016\/j.intimp.2018.12.033_bb0105","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cyto.2008.12.003","article-title":"Evaluating the effects of immunosuppressants on human immunity using cytokine profiles of whole blood","volume":"45","author":"Liu","year":"2009","journal-title":"Cytokine"},{"year":"2009","series-title":"Differential Effect of Cyclosporine and Mycophenolic Acid on the Human Regulatory T Cells and TH-17 Cells Balance","key":"10.1016\/j.intimp.2018.12.033_bb0110"},{"issue":"3","key":"10.1016\/j.intimp.2018.12.033_bb0115","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.cyto.2008.03.006","article-title":"Cyclosporin A inhibits the production of IL-17 by memory Th17 cells from healthy individuals and patients with rheumatoid arthritis","volume":"42","author":"Zhang","year":"2008","journal-title":"Cytokine"},{"issue":"12","key":"10.1016\/j.intimp.2018.12.033_bb0120","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/j.intimp.2011.08.015","article-title":"CNI induced Th17\/Treg imbalance and susceptibility to renal dysfunction in renal transplantation","volume":"11","author":"Li","year":"2011","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2018.12.033_bb0125","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/TP.0b013e3182247b5f","article-title":"Impact of mycophenolic acid and tacrolimus on Th17-related immune response","volume":"92","author":"Abadja","year":"2011","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.intimp.2018.12.033_bb0130","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nri2546","article-title":"Immunoregulatory functions of mTOR inhibition","volume":"9","author":"Thomson","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2018.12.033_bb0135","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.intimp.2015.07.006","article-title":"Differential regulation of Tregs and Th17\/Th1 cells by a sirolimus-based regimen might be dependent on STAT-signaling in renal transplant recipients","volume":"28","author":"Li","year":"2015","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2018.12.033_bb0140","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/imm.12351","article-title":"The effect of mammalian target of rapamycin inhibition on T helper type 17 and regulatory T cell differentiation in vitro and in vivo in kidney transplant recipients","volume":"144","author":"Kim","year":"2015","journal-title":"Immunology"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918304806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918304806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:09:28Z","timestamp":1761584968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576918304806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":28,"alternative-id":["S1567576918304806"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2018.12.033","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Th1, Th2, Th17 cell subsets in two different immunosuppressive protocols in renal allograft recipients (Sirolimus vs mycophenolate mofetil): A cohort study","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2018.12.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}